{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:02:38Z","timestamp":1789657358181,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2208085MH248"],"award-info":[{"award-number":["2208085MH248"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The First Affiliated Hospital of Bengbu Medical University Science Found for Distinguished Young Scholars","award":["2019byyfyjq03"],"award-info":[{"award-number":["2019byyfyjq03"]}]},{"name":"Bengbu Medical College Natural Science Foundation","award":["2022byzd035"],"award-info":[{"award-number":["2022byzd035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03883-2","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T20:23:06Z","timestamp":1744834986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"21","key":"3883_CR1","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","volume":"381","author":"MD Hellmann","year":"2019","unstructured":"Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, et al. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019;381(21):2020\u201331.","journal-title":"N Engl J Med"},{"issue":"6","key":"3883_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"key":"3883_CR3","doi-asserted-by":"publisher","first-page":"1468342","DOI":"10.3389\/fimmu.2024.1468342","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang Z, Xin D, Guan L, Yue B, Zhang Q, et al. Analysis of the treatment efficacy and prognostic factors of PD-1\/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study. Front Immunol. 2024;15:1468342.","journal-title":"Front Immunol"},{"key":"3883_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655716","volume":"11","author":"M Gou","year":"2021","unstructured":"Gou M, Zhang Y, Liu T, Qu T, Si H, Wang Z, et al. The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy. Front Oncol. 2021;11: 655716.","journal-title":"Front Oncol"},{"key":"3883_CR5","doi-asserted-by":"publisher","first-page":"2549295","DOI":"10.1155\/2021\/2549295","volume":"2021","author":"M Gou","year":"2021","unstructured":"Gou M, Qu T, Wang Z, Yan H, Si Y, Zhang Y, et al. Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer. J Immunol Res. 2021;2021:2549295.","journal-title":"J Immunol Res"},{"key":"3883_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.976078","volume":"12","author":"T Li","year":"2023","unstructured":"Li T, Liu T, Zhao L, Liu L, Zheng X, Wang J, et al. Effectiveness and safety of anti-PD-1 monotherapy or combination therapy in Chinese advanced gastric cancer: A real-world study. Front Oncol. 2023;12: 976078.","journal-title":"Front Oncol"},{"issue":"1","key":"3883_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1186\/s12885-023-11312-4","volume":"23","author":"J Huang","year":"2023","unstructured":"Huang J, Xiao Y, Zhou Y, Deng H, Yuan Z, Dong L, et al. Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study. BMC Cancer. 2023;23(1):812.","journal-title":"BMC Cancer"},{"issue":"6","key":"3883_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4174\/astr.2021.100.6.338","volume":"100","author":"Q Yu","year":"2021","unstructured":"Yu Q, Li KZ, Fu YJ, Tang Y, Liang XQ, Liang ZQ, et al. Clinical significance and prognostic value of C-reactive protein\/albumin ratio in gastric cancer. Ann Surg Treat Res. 2021;100(6):338\u201346.","journal-title":"Ann Surg Treat Res"},{"issue":"48","key":"3883_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018219","volume":"98","author":"YJ Fu","year":"2019","unstructured":"Fu YJ, Li KZ, Bai JH, Liang ZQ. C-reactive protein\/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis. Medicine (Baltimore). 2019;98(48): e18219.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3883_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semcancer.2018.05.006","volume":"52","author":"G Cyriac","year":"2018","unstructured":"Cyriac G, Gandhi L. Emerging biomarkers for immune checkpoint inhibition in lung cancer. Semin Cancer Biol. 2018;52(2):269\u201377.","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"3883_CR11","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","volume":"15","author":"JD Wolchok","year":"2009","unstructured":"Wolchok JD, Hoos A, O\u2019Day S, Weber JS, Hamid O, Lebb\u00e9 C, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res. 2009;15(23):7412\u201320.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3883_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4143\/crt.2020.790","volume":"53","author":"SQ Tang","year":"2021","unstructured":"Tang SQ, Tang LL, Mao YP, Li WF, Chen L, Zhang Y, et al. The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients. Cancer Res Treat. 2021;53(2):339\u201354.","journal-title":"Cancer Res Treat"},{"key":"3883_CR13","unstructured":"Pathology Quality Control Center, Chinese Society of Pathology, Pathology Committee of Chinese Society of Clinical Oncology. Consensus on the immunohistochemical tests of PD-L1 in solid tumors (2021 version). Chinese Journal of Pathology. 2021; 50(7): 710\u2013718."},{"issue":"9","key":"3883_CR14","first-page":"632","volume":"24","author":"J Xia","year":"2021","unstructured":"Xia J, Chen Y, Wen S, Du X, Shen B. Peripheral blood inflammation indicators as predictive indicators in immunotherapy of advanced non-small cell lung cancer. Chin J Lung Cancer. 2021;24(9):632\u201345.","journal-title":"Chin J Lung Cancer"},{"key":"3883_CR15","doi-asserted-by":"crossref","unstructured":"Chen Y, Wen S, Xia J, Du X, Wu Y, Pan B, et al. Association of Dynamic Changes in\u00a0Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer. Front Immunol. 2021;5(14):12:672271.","DOI":"10.3389\/fimmu.2021.672271"},{"issue":"3","key":"3883_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","volume":"23","author":"CA Dumitru","year":"2013","unstructured":"Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol. 2013;23(3):141\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"3883_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2326-6066.CIR-15-0313","volume":"4","author":"W Liang","year":"2016","unstructured":"Liang W, Ferrara N. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunol Res. 2016;4(2):83\u201391.","journal-title":"Cancer Immunol Res"},{"issue":"5795","key":"3883_CR18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960\u20134.","journal-title":"Science"},{"key":"3883_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12885-015-1304-z","volume":"15","author":"R Orellana","year":"2015","unstructured":"Orellana R, Kato S, Erices R, Bravo ML, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as Chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290.","journal-title":"BMC Cancer"},{"issue":"5","key":"3883_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390.","journal-title":"Cancer Cell"},{"key":"3883_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijsu.2018.06.037","volume":"56","author":"LX Zhang","year":"2018","unstructured":"Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg. 2018;56:320\u20137.","journal-title":"Int J Surg"},{"issue":"3","key":"3883_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10120-010-0554-3","volume":"13","author":"H Shimada","year":"2010","unstructured":"Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13(3):170\u20136.","journal-title":"Gastric Cancer"},{"key":"3883_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7819-11-112","volume":"11","author":"H Jin","year":"2013","unstructured":"Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, et al. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol. 2013;11:112.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"3883_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","volume":"102","author":"ME Shaul","year":"2017","unstructured":"Shaul ME, Fridlender ZG. Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol. 2017;102(2):343\u20139.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"3883_CR25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","volume":"71","author":"AD Gregory","year":"2011","unstructured":"Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71(7):2411\u20136.","journal-title":"Cancer Res"},{"issue":"5","key":"3883_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101748","volume":"45","author":"B Hou","year":"2021","unstructured":"Hou B, Wang P, Liu T, Chen S, Li T, Zhang S, et al. Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors. Clin Res Hepatol Gastroenterol. 2021;45(5): 101748.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"3883_CR27","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.21037\/jgo-22-1229","volume":"13","author":"J Xiang","year":"2022","unstructured":"Xiang J, Gong W, Sun P, Wang X, Liu A. Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study. J Gastrointest Oncol. 2022;13(6):2874\u201384.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"3883_CR28","first-page":"18","volume":"11","author":"P Caraceni","year":"2013","unstructured":"Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin. Blood Transfus. 2013;11(3):18-S25.","journal-title":"Blood Transfus"},{"issue":"3","key":"3883_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC McMillan","year":"2009","unstructured":"McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"9","key":"3883_CR30","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.3390\/curroncol29090511","volume":"29","author":"H Yu","year":"2022","unstructured":"Yu H, Xu L, Yin S, Jiang J, Hong C, He Y, et al. Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy. Curr Oncol. 2022;29(9):6496\u2013507.","journal-title":"Curr Oncol"},{"issue":"8","key":"3883_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00595-017-1469-y","volume":"47","author":"K Migita","year":"2017","unstructured":"Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, et al. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy. Surg Today. 2017;47(8):1018\u201326.","journal-title":"Surg Today"},{"issue":"5","key":"3883_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.amjsurg.2017.09.032","volume":"216","author":"J Weng","year":"2018","unstructured":"Weng J, Wu H, Wang Z. Clinical usefulness of postoperative C-reactive protein\/albumin ratio in pancreatic ductal adenocarcinoma: Methodological issues. Am J Surg. 2018;216(5):1034.","journal-title":"Am J Surg"},{"key":"3883_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109871","volume":"125","author":"XK Chen","year":"2020","unstructured":"Chen XK, Gu CL, Fan JQ, Zhang XM. P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma. Biomed Pharmacother. 2020;125: 109871.","journal-title":"Biomed Pharmacother"},{"key":"3883_CR34","doi-asserted-by":"crossref","unstructured":"Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, et\u00a0al. The role of CEA, CYFRA21\u20131 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019 8;17(1):74.","DOI":"10.1186\/s12967-019-1828-0"},{"key":"3883_CR35","doi-asserted-by":"publisher","first-page":"175883592095299","DOI":"10.1177\/1758835920952994","volume":"12","author":"FG Dall'Olio","year":"2020","unstructured":"Dall\u2019Olio FG, Abbati F, Facchinetti F, Massucci M, Melotti B, Squadrilli A, et al. CEA and CYFRA 21\u20131 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors. Ther Adv Med Oncol. 2020;12:1758835920952994.","journal-title":"Ther Adv Med Oncol"},{"key":"3883_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.6163212","volume":"212","author":"H Koprowski","year":"1981","unstructured":"Koprowski H, Herlyn M, Steplewski Z, Sears HF. Specific antigen in serum of patients with colon carcinoma. Science. 1981;212:53\u20135.","journal-title":"Science"},{"key":"3883_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300366120","volume":"120","author":"J Wu","year":"2023","unstructured":"Wu J, Wang X, Huang Y, Zhang Y, Su S, Shou H, et al. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors. Proc Natl Acad Sci USA. 2023;120: e2300366120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3883_CR38","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aaw3145","volume":"364","author":"DD Engle","year":"2019","unstructured":"Engle DD, Tiriac H, Rivera KD, Pommier A, Whalen S, Oni TE, et al. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science. 2019;364:1156\u201362.","journal-title":"Science"},{"issue":"3","key":"3883_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1158\/2159-8290.CD-20-0519","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, et al. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer. Cancer Discov. 2021;11(3):736\u201353.","journal-title":"Cancer Discov"},{"key":"3883_CR40","doi-asserted-by":"publisher","first-page":"1528138","DOI":"10.3389\/fonc.2024.1528138","volume":"14","author":"T Du","year":"2025","unstructured":"Du T, Zou J, Yang Y, Xie H, Pang H, Zhuang W, et al. CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment. Front Oncol. 2025;14:1528138.","journal-title":"Front Oncol"},{"issue":"6","key":"3883_CR41","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s10120-019-00973-5","volume":"22","author":"D Takahari","year":"2019","unstructured":"Takahari D, Chin K, Ishizuka N, Takashima A, Minashi K, Kadowaki S, et al. Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-na\u00efve, HER2-positive advanced gastric cancer. Gastric Cancer. 2019;22(6):1238\u201346.","journal-title":"Gastric Cancer"},{"issue":"2","key":"3883_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3748\/wjg.v24.i2.266","volume":"24","author":"YK Wang","year":"2018","unstructured":"Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol. 2018;24(2):266\u201373.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3883_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000012152","volume":"59","author":"H Amemiya","year":"2000","unstructured":"Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology. 2000;59(2):145\u201351.","journal-title":"Oncology"},{"issue":"6","key":"3883_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00535-002-1099-y","volume":"38","author":"S Kamei","year":"2003","unstructured":"Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, et al. Evaluation of vegf and vegf-c expression in gastric cancer cells producing alpha-fetoprotein. J Gastroenterol. 2003;38(6):540\u20137.","journal-title":"J Gastroenterol"},{"key":"3883_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101737","volume":"36","author":"Y Li","year":"2023","unstructured":"Li Y, Lin Y, Zhao L, Yang C, Wang B, Gao Z, Ye Y, Wang S, Shen Z, et al. Characteristics of alpha-fetoprotein-positive gastric cancer revealed by analysis of cancer databases and transcriptome sequencing data. Transl Oncol. 2023;36: 101737.","journal-title":"Transl Oncol"},{"issue":"10","key":"3883_CR46","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1002\/cam4.5883","volume":"12","author":"Y Mei","year":"2023","unstructured":"Mei Y, Li M, Wen J, Kong X, Li J. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer. Cancer Med. 2023;12(10):12018\u201333.","journal-title":"Cancer Med"},{"issue":"3","key":"3883_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jclinpath-2017-204535","volume":"71","author":"K Arora","year":"2018","unstructured":"Arora K, Bal M, Shih A, Moy A, Zukerberg L, Brown I, et al. etal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis. J Clin Pathol. 2018;71(3):221\u20137.","journal-title":"J Clin Pathol"},{"key":"3883_CR48","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1200\/JCO.2015.61.6870","volume":"33","author":"VL Chiou","year":"2015","unstructured":"Chiou VL, Burotto M. Pseudoprogression and immune-related response in solidtumors. J Clin Oncol. 2015;33:3541\u20133.","journal-title":"J Clin Oncol"},{"key":"3883_CR49","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jtho.2018.08.2027","volume":"13","author":"DR Gandara","year":"2018","unstructured":"Gandara DR, von Pawel J, Mazieres J, et al. Atezolizumab treatment beyond progression in advanced NSCLC: results from the randomized, phase III OAK study. J Thorac Oncol. 2018;13:1906\u201318.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3883_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","volume":"7","author":"S Das","year":"2019","unstructured":"Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019;7(1):306.","journal-title":"J Immunother Cancer"},{"issue":"6371","key":"3883_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103.","journal-title":"Science"},{"issue":"3","key":"3883_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamaoncol.2017.2925","volume":"4","author":"K Haratani","year":"2018","unstructured":"Haratani K, Hayashi H, Chiba Y, Kudo K, Yonesaka K, Kato R, et al. Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer. JAMA Oncol. 2018;4(3):374\u20138.","journal-title":"JAMA Oncol"},{"key":"3883_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejca.2018.10.014","volume":"109","author":"J Rogado","year":"2019","unstructured":"Rogado J, Sanchez-Torres JM, Romero-Laorden N, Ballesteros AI, Pacheco- Barcia V, Ramos-Levi A, et al. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients. Eur J Cancer. 2019;109:21\u20137.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3883_CR54","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41598-020-79397-6","volume":"11","author":"R Matsukane","year":"2021","unstructured":"Matsukane R, Watanabe H, Minami H, et al. Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events. Sci Rep. 2021;11(1):1324.","journal-title":"Sci Rep"},{"issue":"4","key":"3883_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.21037\/tlcr.2019.06.06","volume":"8","author":"M Jove","year":"2019","unstructured":"Jove M, Vilari\u00f1o N, Nadal E. Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer. Transl Lung Cancer Res. 2019;8(4):364\u20138.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"3883_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000538","volume":"8","author":"N Martinez Chanza","year":"2020","unstructured":"Martinez Chanza N, Xie W, Issa M, Dzimitrowicz H, Tripathi A, Beuselinck B, et al. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study. J Immunother Cancer. 2020;8(1): e000538.","journal-title":"J Immunother Cancer"},{"key":"3883_CR57","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaoncol.2015.4368","volume":"2","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Sullivan RJ, Ott PA, et al. Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders. JAMA Oncol. 2016;2:234\u201340.","journal-title":"JAMA Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03883-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03883-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03883-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:03:34Z","timestamp":1744880614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03883-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03883-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Bengbu Medical College (Ethics Approval Number: Lunke Approval [2023] No. 378).The requirement of informed consent was exempted by the IRB due to its retrospective nature. This research involved analyzing data that did not include personal identifying information. Since the data analyzed pertained to patients who had already completed treatment, there was no direct risk or benefit to individuals. Consequently, a waiver of consent was submitted and approval for this study was obtained. The study was conducted in accordance with theethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}